Stockreport

Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recur...

Precigen, Inc.  (PGEN) 
Last precigen, inc. earnings: 3/2 04:05 pm Check Earnings Report
PDF 15 out of 18 complete responders (83%) demonstrate continued complete response with median follow-up of 36 months [Read more]